Literature DB >> 21992005

Ibuprofen or diclofenac is associated with more severe acute kidney injury in nephropathia epidemica.

Robert Wagner1, Ursel Leicht-Biener, István Mucsi, Karlheinz Seitz.   

Abstract

OBJECTIVE: In many parts of Europe, nephropathia epidemica (NE) is an endemic zoonosis. After a flu-like prodrome, this viral disease often manifests with acute kidney injury. Use of non-steroidal anti-inflammatory drugs is discouraged during the disease, but no data from clinical investigations are available on the association between disease course and the use of analgesics.
MATERIAL AND METHODS: The charts of 59 patients admitted with NE to a hospital in 2007 were retrospectively analysed. Creatinine levels were compared between users of different analgesics.
RESULTS: Patients taking analgesics before admission had higher peak creatinine levels, but not after adjustment for confounders. The subgroup taking ibuprofen or diclofenac had higher initial and peak creatinine levels than the group who did not, even after adjustment for confounders.
CONCLUSION: Since NE cannot be accurately diagnosed in the early disease phase, metamizole, acetaminophen or acetylsalicylic acid may be preferable analgesics to ibuprofen or diclofenac for flu-like symptoms in endemic areas.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21992005     DOI: 10.3109/00365599.2011.625041

Source DB:  PubMed          Journal:  Scand J Urol Nephrol        ISSN: 0036-5599


  2 in total

1.  Urinary Neutrophil Gelatinase-Associated Lipocalin (NGAL) and proteinuria predict severity of acute kidney injury in Puumala virus infection.

Authors:  Hanno Bunz; Peter Weyrich; Andreas Peter; Dorothea Baumann; Otto Tschritter; Martina Guthoff; Robert Beck; Gerhard Jahn; Ferruh Artunc; Hans-Ulrich Häring; Nils Heyne; Robert Wagner
Journal:  BMC Infect Dis       Date:  2015-10-27       Impact factor: 3.090

2.  Bioclinical Test to Predict Nephropathia Epidemica Severity at Hospital Admission.

Authors:  Maxime Hentzien; Stéphanie Mestrallet; Pascale Halin; Laure-Anne Pannet; Delphine Lebrun; Moustapha Dramé; Firouzé Bani-Sadr; Jean-Marc Galempoix; Christophe Strady; Jean-Marc Reynes; Christian Penalba; Amélie Servettaz
Journal:  Emerg Infect Dis       Date:  2018-06       Impact factor: 6.883

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.